Ipsen and GENFIT Announce Positive Results from Phase III ELATIVE Trial of Elafibranor in Patients with Primary Biliary Cholangitis, a Rare Cholestatic Liver Disease
Trial met primary endpoint with a statistically significant higher percentage of patients achieving a clinically meaningful cholestasis response compared to placebo
Elafibranor was well tolerated with a safety profile consistent with previous... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 30, 2023 Category: Pharmaceuticals Source Type: clinical trials
Observational Trial Evaluating Elevated Factor VIII Related Labs as a Biomarker for Incomplete Relapse Recovery
Condition: Multiple Sclerosis, Relapsing-Remitting Intervention: Diagnostic Test: blood tests drawn days 1, 8, 22 and 90 of the study Sponsors: Dignity Health Medical Foundation; Dolly Roy MD PhD (author); J. Michael Menke (statistician); Sabeen Lulu MD (Principal Investigator) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2023 Category: Research Source Type: clinical trials
Influence of Stress on Encoding and Prediction
Conditions: Stress; Episodic Encoding; Statistical Learning Interventions: Behavioral: Socially Evaluated Cold Pressor Test; Behavioral: Control Sponsors: Yale University; National Institute of Mental Health (NIMH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 27, 2023 Category: Research Source Type: clinical trials
DYNAMIC AI: Digital Innovation With Remote Management and Predictive Modelling to Integrate COPD Care With Artificial Intelligence-based Insights: An Acceptability, Feasibility and Safety Study
Condition: COPD Intervention: Device: AI Insights Application Sponsors: NHS Greater Glasgow and Clyde; Lenus Health; University of Glasgow Robertson Centre for Bio Statistics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
